Clinical Trial Update: Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating induction chemotherapy before surgery in operable non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: WITHDRAWN